Abstract
Objective: To investigate whether smoking, alcohol intake, female hormonal or anthropometric factors affect melanoma risk. Methods: Using Cox proportional hazards regression analyses, we analyzed 68,588 white subjects (79% female) from the US Radiologic Technologists (USRT) Study who were cancer-free (other than non-melanoma skin cancer) as of the first of two self-administered questionnaires. Follow-up covered 698,028 person-years, with 207 cases of melanoma. Results: We found that melanoma risk was not associated with height, weight or BMI, nor with age at menarche, menopausal status, use of hormone replacement therapy, parity, age at first birth or oral contraceptive use. Melanoma risk was elevated with increasing alcohol use (RR: 2.1; 95% CI: 0.9–4.8, for >14 drinks/week compared to never drinking; (p(trend) = 0.08)). Smoking for long durations compared to never smoking was inversely related to melanoma risk (RR: 0.6; 0.3–1.3; ≥30 years; p(trend) = 0.03), though risk was not associated with number of packs smoked per day. Conclusions: None of the anthropometric or female reproductive/hormonal factors evaluated were related to melanoma risk. It is unclear whether the positive association with alcohol intake and inverse association with smoking for long duration are causal. The alcohol and smoking findings warrant detailed assessment in studies with substantial statistical power where potential biases can be more fully evaluated.
Similar content being viewed by others
References
Armstrong BK, English DR (1996) Cutaneous malignant melanoma. In: Schottenfeld D, Fraumeni, JF, Jr. eds. Cancer Epidemiology and Prevention. 2nd edn New York: Oxford University Press, pp. 1282-1312.
Liu T, Soong S-J (1996) Epidemiology of malignant melanoma. Surg Clin North Am 76: 1205-1222.
Weinstock MA (1998) Issues in the epidemiology of melanoma. Hematol Oncol Clin North Am. 12: 681-698.
Bain C, Hennekens CH, Speizer FE, Rosner B, Willett W, Belanger C (1982) Oral contraceptive use and malignant melanoma. J Natl Cancer Inst 68: 537-539.
Beral V, Evans S, Shaw H, Milton G (1984) Oral contraceptive use and malignant melanoma in Australia. Br J Cancer 50: 681-685.
Feskanich D, Hunter DJ, Willett WC, et al. (1990) Oral contraceptive use and risk of melanoma in premenopausal women. Br J Cancer 81: 918-923.
Gallagher RP, Elwood JM, Hill GB, Coldman AJ, Threlfall WJ, Spinelli JJ (1985) Reproductive factors, oral contraceptives and risk of malignant melanoma: Western Canada melanoma study. Br J Cancer 52: 901-907.
Green A, Bain C, McLennan R, Siskind V (1986) Risk factors for cutaneous melanoma in Queensland. Recent Res Cancer Res 102: 76-97.
Holly EA, Cress RD, Ahn DK (1994) Cutaneous melanoma in women: ovulatory life, menopause, and use of exogenous estrogen. Cancer Epidemiol Biomarkers Prev 3: 661-668.
Holly EA, Cress RD, Ahn DK (1995) Cutaneous melanoma in women III. Reproductive factors and oral contraceptive use. Am J Epidemiol 141: 943-950.
Holly EA, Weiss NS, Liff JM (1983) Cutaneous melanoma in relation to exogenous hormones and reproductive factors. J Natl Cancer Inst 70: 827-831.
Holman CDJ, Armstrong BK, Heenan PJ (1984) Cutaneous malignant melanoma in women: exogenous sex hormones and reproductive factors. Br J Cancer 50: 673-680.
Kirkpatrick CS, White E, Lee JAH (1994) Case-control study of malignant melanoma in Washington State II. Diet, alcohol, and obesity. Am J Epidemiol 139: 869-80.
Lambe M, Tho¨ rn M, Spare´ n P, Bergstro¨ m R, Adami HO (1996) Malignant melanoma: reduced risk associated with early childbearing and multiparity. Melanoma Res 6: 147-153.
Osterlind A, Tucker MA, Stone BJ, Jensen OM (1988) The Danish case-control study of cutaneous malignant melanoma III. Hormonal and reproductive factors in women. Int J Cancer 42: 821-824.
Osterlind A, Tucker MA, Stone BJ, Jensen OM (1988) The Danish case-control study of cutaneous malignant melanoma. IV. No association with nutritional factors, alcohol, smoking or hair dyes. Int J Cancer 42: 825-828.
Palmer JR, Rosenberg L, Strom BL, et al. (1992) Oral contraceptive use and risk of cutaneous malignant melanoma. Cancer Causes Control 3: 547-554.
Shors AR, Solomon C, McTiernan A, White E (2001) Melanoma risk in relation to height, weight, and exercise. Cancer Causes Control 12: 599-606.
Smith MA, Fine JA, Barnhill RL, Berwick M (1998) Hormonal and reproductive influences and risk of melanoma in women. Int J Epidemiol 27: 751-757.
Stryker WS, Stampfer MJ, Stein EA, et al. (1990) Diet, plasma levels of beta-carotene and alpha-tocopherol, and risk of malignant melanoma. Am J Epidemiol 131: 597-611.
Veirod MB, Thelle DS, Laake P (1997) Diet and risk of cutaneous malignant melanoma: a prospective study of 50,757 Norwegian men and women. Int J Cancer 71: 600-604.
Westerdahl J, Olsson H, Masback A, Ingvar C, Jonsson N (1996) Risk of malignant melanoma in relation to drug intake, alcohol, smoking and hormonal factors. Br J Cancer 73: 1126-1131.
Zanetti R, Franceschi S, Rosso S, Bidoli E, Colonna S (1990) Cutaneous malignant melanoma in females: the role of hormonal and reproductive factors. Int J Epidemiol 19: 522-526.
Boice JD, Mandel JS, Doody MM, et al. (1992) A health survey of radiologic technologists. Cancer 69: 586-598.
Doody MM, Mandel JS, Lubin JH, Boice JD, Jr. (1998) Mortality among United States radiologic technologists, 1926-1990. Cancer Causes Control 9: 67-75.
Percy CL, Miller BA, Gloeckler-Ries LA (1990) Effect of changes in cancer classification and the accuracy of cancer death certifi-cates on trends in cancer mortality. Ann New York Acad Sci 609: 87-99.
Greenlee RT, Hill-Harmon MB, Murray T, Thun M 2001 Cancer Statistics, 2001 CA. Cancer J Clin 51: 15-36.
Scotto J, Fears TR, Fraumeni, JF, Jr. (1996) Solar radiation. In: Schottenfeld D, Fraumeni, JF, Jr. eds. Cancer Epidemiology and Prevention. 2nd ed. New York: Oxford University Press, pp. 355-372.
Little RJA, Rubin DB (1987) Statistical Analysis with Missing Data. New York: John Wiley & Sons, Inc. pp. 65-67.
Groves RM, Dillman DA, Eltimpe JL, Little RJA (2002) Survey Nonresponse. New York: John Wiley & Sons, Inc. pp. 330-333, 419.
Korn EL, Graubard BI, Midthune D (1997) Time-to-event analysis of longitudinal follow-up of a survey: choice of the timescale. Am J Epidemiol 145: 72-80.
Le MG, Cabanes PA, Desvignes V, Chanteau MF, Mlika N, Avril MF (1992) Oral contraceptive use and risk of cutaneous malignant melanoma in a case-control study of French women. Cancer Causes Control 3: 199-205.
Thune I, Olsen A, Albrektsen G, Tretli S (1993) Cutaneous malignant melanoma: association with height, weight and bodysurface area, a prospective study in Norway. Int J Cancer 55: 555-561.
Cutler C, Foulkes WD, Brunet JS, Flanders TY, Shibata H, Narod SA (1996) Cutaneous malignant melanoma in women is uncommonly associated with a family history of melanoma in first-degree relatives: a case-control study. Melanoma Res 6: 435-440.
Williams RR, Horm JW (1977) Association of cancer sites with tobacco and alcohol consumption and socioeconomic status of patients: interview study from the Third National Cancer Survey. J Natl Cancer Inst 58: 525-547.
Bain C, Green A, Siskind V, Alexander J, Harvey P (1993) Diet and melanoma: an exploratory case-control study. Ann Epidemiol 3: 235-238.
Adami HO, McLaughlin JK, Using AW, et al. (1992) Alcoholism and cancer risk: a population-based cohort study. Cancer Causes Control 3: 419-425.
Holman CDJ, Armstrong BK, Heenan PJ, et al. (1986) The Causes of malignant melanoma: results from the West Australian Lions Melanoma Research Project. Recent Res Cancer Res 102: 18-37.
Green A, McCredie M, MacKie R, et al. (1999) A case-control study of melanomas of the soles and palms (Australia and Scotland). Cancer Causes Control 10: 21-25.
Siemiatycki J, Krewski D, Franco E, Kaiserman M (1995) Associations between cigarette smoking and each of 21 types of cancer: a multi-site case-control study. Int J Cancer 24: 504-514.
De Hertog SAE, Wensveen CAH, Bastiaens MT, et al. (2001) Relation between smoking and skin cancer. J Clin Onc 19: 231-238.
Santmyire BR, Feldman SR, Fleischer AB (2001) Lifestyle highrisk behaviors and demographics may predict the level of participation in sun-protection behaviors and skin cancer primary prevention in the United States. Cancer 92: 1315-1324.
Van Durme DJ, Ferrante JM, Pal N, Wathington D, Roetzheim RG, Gonzalez EC (2000) Demographic predictors of melanoma stage at diagnosis. Arch Fam Med 9: 606-611.
Rigel DS, Friedman RJ, Levine J, Kopf AW, Levenstein M (1981) Cigarette smoking and malignant melanoma: prognostic implications. J Dermatol Surg Oncol 7: 889-891.
Shaw HM, Milton GW (1981) Smoking and the development of metastasis from malignant melanoma. Int J Cancer 28: 153-156.
Aubry F, MacGibbon B (1985) Risk factors of squamous cell carcinoma of the skin: a case-control study in the Montreal region. Cancer 55: 907-911.
Grodstein F, Speizer FE, Hunter DJ (1995) A prospective study of incident squamous cell carcinoma of the skin in the Nurses' Health Study. J Natl Cancer Inst 87: 1061-1066.
Coogan PF, Geller A, Adams M, Benjes LS, Koh HK (2001) Sun protection practices in preadolescents and adolescents: a schoolbased survey of almost 25, 000 Connecticut schoolchildren. J Am Acad Dermatol 44: 512-519.
Hall HI, Jones SE, Saraiya M (2001) Prevalence and correlates of sun screen use among US high school students. J Sch Health 71: 453-457.
Chalmers K, Sequire M, Brown J (2002) Tobacco use and baccalaureate nursing students: a study of their attitudes, beliefs and personal behaviours. J Adv Nurs 40: 17-24.
Kimm SYS, Glynn NW, Kriska AM, et al. (2002) Decline in physical activity in black girls and white girls during adolescence. N Eng J Med 347: 709-715.
Buckman SY, Gresham A, Hale P, et al. (1998) COX-2 expression is induced by UVB exposure in human skin: Implications for the development of skin cancer. Carcinogenesis 5: 723-729.
Denkert C, Kobel M, Berger S, et al. (2001) Expression of cyclooxygenase 2 in human malignant melanoma. Cancer Res 61: 303-308.
Harris RE, Beebe-Donk J, Namboodiri KK (2001) Inverse association of non-steroidal anti-inflammatory drugs and malignant melanoma among women. Oncol Repts 8: 655-657.
Mills CM, Hill SA, Marks R (1993) Altered inflammatory response in smokers. BMJ 307: 911.
Mills CM, Hill SA, Marks R (1997) Transdermal nicotine suppresses cutaneous inflammation. Arch Dermatol 133: 823-825.
Cornwell ML, Comstock GW, Holick MF, Bush TL. Prediagnostic serum levels of 1,25-dihydroxyvitamin D and malignant melanoma. (1992) Photodermatol Photoimmunol Photomed 9: 109-112.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Freedman, D.M., Sigurdson, A., Doody, M.M. et al. Risk of melanoma in relation to smoking, alcohol intake, and other factors in a large occupational cohort. Cancer Causes Control 14, 847–857 (2003). https://doi.org/10.1023/B:CACO.0000003839.56954.73
Issue Date:
DOI: https://doi.org/10.1023/B:CACO.0000003839.56954.73